[Defense of the esophageal mucosa as a therapeutic target in gastroesophageal reflux disease]

Gastroenterol Hepatol. 2004 Apr;27(4):274-84. doi: 10.1016/s0210-5705(03)70458-0.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Ulcer Agents / therapeutic use
  • Clinical Trials as Topic
  • Esophagitis, Peptic / drug therapy
  • Esophagitis, Peptic / pathology
  • Esophagitis, Peptic / prevention & control*
  • Esophagogastric Junction / pathology
  • Esophagoscopy
  • Gastroesophageal Reflux / complications
  • Gastroesophageal Reflux / drug therapy*
  • Gastroesophageal Reflux / pathology
  • Humans
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / pathology

Substances

  • Anti-Ulcer Agents